Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Fallopian Tube Neoplasms × Etoposide × Clear all

Phase

Status

Sponsor Class

NETWORK 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 3 Multiple Myeloma 2 Hematologic Neoplasms 2 Ovarian Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Fallopian Tube Neoplasms 1

Interventions

taxane 2 Surgical Procedures, Operative 2 Poly(ADP-ribose) Polymerase Inhibitors 2 Neoadjuvant Therapy 2 Carboplatin 2 Bevacizumab 2 olaparib 1 niraparib 1 cediranib 1 Platinum 1 Paclitaxel 1 Maintenance 1 Etoposide 1 Drug Therapy 1 Diagnostic Imaging 1 CP protocol 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01669226 2016-12-19

AICE

Shanghai Gynecologic Oncology Group

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡